Effects of Medications on Physiological Measures of Auditory Function

Michael J. Cevette; Theodore J. Glattke

doi:10.1055/s-2003-41220

Seminars in Hearing, Inhaltsverzeichnis

Semin Hear 2003; 24(3): 223-234
DOI: 10.1055/s-2003-41220

Effects of Medications on Physiological Measures of Auditory Function

Michael J. Cevette¹ , Theodore J. Glattke²

¹Mayo Clinic, Scottsdale, Arizona
²University of Arizona, Tucson, Arizona

Abstract

ABSTRACT

Physiologic measures that range from evaluation of the status of the middle ear to myogenic potentials linked to vestibular stimulation are important supplements to behavioral measures of hearing. All of these measures are influenced by medications that may be used to treat symptoms or otherwise help to manage patients who present with multiple handicaps. Some of the interactions occur because of the medication's direct influence on the auditory system, whereas others stem from general depressant effects on the central nervous system. In general, responses obtained from the periphery tend to be vulnerable to cochleotoxic or vestibulotoxic agents that may influence the response before they produce a measurable hearing loss. In contrast, endogenous responses are influenced markedly by level of sedation or sleep state. The clinician employing physiologic measures must be aware of the patient's medication history to interpret properly the outcomes of physiological tests.

KEYWORDS

Electrophysiology - evoked potentials - acoustic reflexes - medications

Volltext

Referenzen

REFERENCES

1 Magnuson, B. Physiology of the Eustachian tube and middle ear pressure regulation. In: Jahn A, Santos-Sacchi J, eds. Physiology of the Ear, 2nd ed San Diego, CA: Singular 2001 : 75-99
2 Buckingham R, Ferrer J. Observations of middle ear pressures. Ann Otol Rhin Laryngol . 1980; 89(Suppl 68) 56-61
3 Buckingham R, Stuart D, Gieck H, Girgis S, McGee T. Experimental evidence against middle ear oxygen absorption. Laryngoscope . 1984; 95 437-442
4 Kuschnir H, Rust M, Eisler, K. Changes of pressure within the middle ear during various kinds of anaesthesia. Laryngorhinoologie . 1981; 60 418-420
5 Rees G, Freeland, A. The effect of anaesthesia on tympanograms of children undergoing grommet insertion. Clin Otolarygol & Allied Sciences . 1992; 17 200-202
6 Nagai T, Nagai M, Nagata Y, Morimitsu T. The effects of anesthesia of the tympanic membrane on Eustachian tube function. Arch Oto-Rhino-Laryngol . 1989; 246 210-212
7 Toth L, Lampe I, Dioszeghy P, Repassy G. The diagnostic value of stapedius reflex and stapedius reflex exhaustion in myasthenia gravis. Electromyogr Clin Neurophysiol . 2000; 40 17-20
8 Morioka W, Neff P, Boisseranc T, Hartman P, Cantrell R. Audiotympanometric findings in mysasthenia gravis. Arch Otolaryngol . 1976; 102 211-213
9 Neff P, Morioka W, Sample P, Cantrell R. Audiometric and tympanometric monitoring of a disease affecting nerve-muscle transmission. Audiology . 1980; 19 293-309
10 Ruth R, Johns M, Gal T. Acoustic reflex response during curare-induced weakness. Ann Otol Rhinol Laryngol . 1980; 89 188-193
11 Ruth R, Arora N, Gal T. Stapedius reflex in curarized subjects: an index of neuromuscular weakness. J Appl Physiol . 1982; 52 416-420
12 Bauch C, Robinette M. Alcohol and the acoustic reflex: effects of stimulus spectrum, subject variability and sex. J Am Audiol Soc . 1978; 4 104-112
13 Robinette M, Alper R, Brey R. The effects of alcohol on the acoustic reflex relaxation index. J Audiol Res . 1981; 21 159-165
14 Cohill E, Greenberg H. Effects of ethyl alcohol on the contralateral and ipsilateral acoustic reflex threshold. J Speech Hear Res . 1979; 22 289-294
15 Uhles M, Clark W, Anch M. Effects of alcohol on the acoustic reflex threshold in the chinchilla. Acta Otolaryngol (Stockh) . 2000; 120 523-528
16 Salonen M, Laurikainen E, Sipila J, Johansson R, Kanto J. The effect of flunitrazepam on acoustic reflex-a methodological pilot study. Methods Find Exp Clin Pharmacol . 1988; 10 213-217
17 Niswander P, Helfner-Mitchell F. Observations on the acoustic reflex threshold in institutionalized retarded adults taking mellaril and/or thorazine. Ear Hear . 1988; 9 9-14
18 Hall III J. The effects of high-dose barbiturates on the acoustic reflex and auditory evoked responses. Two case reports. Acta Otolaryngol (Stockh) . 1985; 100 387-398
19 Farkas Z. Acoustic reflex and general anesthesia. Scand Audiol . 1983; (Suppl 17) 43-46
20 Dinc O, Nagel D. Measurement of the acoustically evoked stapedius reflex in intubation anesthesia. HNO . 1986; 34 75-77
21 Katbamma B. Homnick D, Marks J. Effects of chronic tobramycin treatment on distortion product otoacoustic emissions. Ear Hear . 1999; 20 393-402
22 Qiu C, Salvi R, Ding D, Burkard R. Inner hair cell loss leads to enhanced response amplitudes in auditory cortex of unanesthetized chinchillas: evidence for increased system gain. Hear Res . 2000; 139 153-171
23 Stavroulaki P, Vossinakis I, Dinopoulou D. et al . Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis. Arch Otolaryngol Head Neck Surg . 2002; 128 150-155
24 Steward C, Hudspeth A. Effects of salicylates and aminoglycosides on spontaneous otoacoustic emissions in the Tokay gecko. Proc Nat Acad Sci U S A . 2000; 97 454-459
25 Wier C, Pasanen E, McFadden D. Partial dissociation of spontaneous otoacoustic emissions and distortion products during aspirin use in humans. J Acoust Soc Am . 1988; 84 230-237
26 Lue A, Zhao H, Brownell W. Chlorpromazine alters outer hair cell electromotility. Otolaryngol Head Neck Surg . 2001; 125 71-76
27 Hess M, Lamprechet A, Kirkopoulos S, Fournell A. Measuring evoked otoacoustic emissions at various times during intubation anesthesia. Folia Phoniatrica . 1991; 43 68-73
28 Manley G, Schulze M, Oeckinghaus H. Otoacoustic emissions in a songbird. Hear Res . 1987; 26 256-266
29 Dallos P, Cheatham M A. Production of cochlear potentials by inner and outer hair cells. J Acoust Soc Am . 1976; 60 510-512
30 Neely S T, Kim D O. A model for active elements in cochlear biomechanics. J Acoust Soc Am . 1986; 79 1472-1480
31 Puel J L. Chemical synaptic transmission in the cochlea. Prog Neurobiol . 1995; 47 449-476
32 Cheung N Y, Bonventre J V, Malis C D, Leaf A. Calcium and ischemic injury. N Engl J Med . 1986; 314 1670-1676
33 Peul J, Ruel J, Guitton M, Wang J, Pujol R. The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol Neuroototol . 2002; 7 49-54
34 Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol Rev . 1993; 73 309-373
35 Ferraro J A, Durrant J D. Electrocochleography. In: Katz J ed. Handbook of Audiology Baltimore, MD: Lippincott Williams & Wilkins; 2002
36 Moore R D, Smith C R, Lietman P S. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis . 1984; 149 23-30
37 Brouet G, Marche J, Chevallier J. et al . Etude experimentale et clinique de la kanamycine dans l'infection tuberculeuse. Rev Tuberc Pneumol . 1959; 23 949-988
38 Wu W, Sha S, Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol . 2002; 7 171-174
39 Conlon B J, Aran J M, Erre J P, Smith D W. Attention of aminoglycoside-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid. Hear Res . 1999; 128 40-44
40 Lim D J. Effects of noise and ototoxic drugs at the cellular level in the cochlea: a review. Am J Otolaryngol . 1986; 7 73-99
41 Keene M, Graham J M. Clinical monitoring of the effects of gentamicin by electrocochleography. J Laryngol Otol . 1984; 98 11-21
42 Collins P W, Twine J M. The ototoxic effects of different doses of gentamicin on the cochlea of pigmented guinea pigs. Br J Audiol . 1985; 19 257-264
43 Ramsden R T, Latif A, O'Malley S. Electrocochleographic changes in acute salicylate overdosage. J Laryngol Otol . 1985; 99 1269-1273
44 Puel J L, Bobbin R P, Fallon M. Salicylate, meclofenamate, meclofenamate, and quinine on cochlear potentials. Otolaryngol Head Neck Surg . 1990; 102 66-73
45 Kumagai M. Effect of intravenous injection of aspirin on the cochlea [In Japanese]. Hokkaido Igaku Zasshi . 1992; 67 216-233
46 Didier A, Miller J M, Nuttall A L. The vascular component of sodium salicylate ototoxicity in the guinea pig. Hear Res . 1993; 69 199-206
47 Rybak L P. Furosemide ototoxicity: clinical and experimental aspects. Laryngoscope . 1985; 95(Suppl 38) 1-14
48 Wang L. Effects of furosemide on endocochlear potentials, auditory action potentials and summating potentials and the changes of inner ear pathology [In Chinese]. Chinese J Otorhinolaryngol . 1992; 27 70-124
49 Rybak L P, Whitworth C, Weberg A, Scott V. Effects of organic acids on the edema of the stria vascularis induced by furosemide. Hear Res . 1992; 59 75-84
50 Ikeda K, Kusakarei J, Takassaka T, Saito Y. The Ca2+ activity of cochlear endolymph of the guinea pig and the effect of inhibitors. Hear Res . 1987; 26 117-125
51 Waters G S, Ahmad M, Katsarkas A, Stainimir G, McKay J. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administraiton. Ear Hear . 1991; 12 91-102
52 Dickerson R N, Brown R O. Hypomagnesemia in hospitalized patients receiving nutritional support. Heart Lung . 1985; 14 561-567
53 Lam M, Adelstein D J. Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin. Am J Kidney . 1986; 8 164-203
54 Kohn S, Fradis M, Pratt H. et al . Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Laryngoscope . 1988; 9 865-871
55 Nakai Y, Konish K, Chang K C. et al . Ototoxicity of the anticancer drug cisplatin. An experimental study. Acta Otolaryngol . 1982; 93 227-232
56 Saito T, Aran J M. Comparative ototoxicity of cisplatin during acute and chronic treatment. J Otorhinolaryngol Relat Spec . 1994; 56 315-320
57 Nakagawa T, Kakehata S, Akaike N. et al . Effect of Ca²⁺ antagonist and aminoglycoside antibiotics on Ca²⁺ current in isolated outer hair cells of guinea pig cochlea. Brain Res . 1992; 580 345-347
58 Bobbin R P, Jastreboff P J, Fallon M, Littman T. Nimodipine, an L-channel Ca²⁺ antagonist, reverses the negative summating potential recorded from the guinea pig cochlea. Hear Res . 1990; 46 277-288
59 Yamamoto T, Kakehata S, Saito T, Saito H, Akaike N. Cisplatin blocks voltage-dependent calcium current in dissociated outer hair cells of guinea-pig cochlea. Brain Res . 1994; 648 296-298
60 Hamers F P, Klis S FL, Gispen W H, Smoorenburg G F. Application of a neuroprotective ACTH_(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs. Eur Arch Otorhinolaryngol . 1994; 251 23-29
61 Moller A R, Jannetta P J, Sekhar L N. Contributions from the auditory nerve to the brain-stem auditory evoked potentials (BAEPs): results of intracranial recording in man. Electroencephalogr Clin Neurophysiol . 1988; 71 198-211
62 Hotz M A, Allum J H, Kaufmann G. et al . Shifts in auditory brainstem response latencies following plasma-level-controlled aminoglycoside therapy. Eur Arch Oto-Rhino-Laryngol . 1990; 147 202-205
63 Sweetow R W, Will T I. Progression of hearing loss following completion of chemotherapy and radiation therapy: case report. J Am Acad Audiol . 1993; 4 360-363
64 Mokotoff B, Schulmann-Galambos C, Galambos R. Brain stem auditory evoked responses in children. Arch Otolaryngol . 1977; 103 38-43
65 Palaskas C W, Wilson M J, Dobie R A. , Electrophysiologic assessment of low-frequency hearing: sedation effects. Otolaryngol Head Neck Surg . 1989; 101 434-441
66 Martin H, Mishler E. Intraoperative monitoring of auditory evoked potentials and facial nerve electromyography. In: Katz J, ed. Handbook of Clinical Audiology Baltimore, MD: Lippincott Williams & Wilkins; 2002: 323-348
67 Purdie J A, Cullen P M. Brainstem auditory evoked response during propofol anesthesia in children. Anesthesia . 1993; 48 192-195
68 Nuwer M R. Brainstem auditory monitoring and related techniques. In: Nuwer MR, ed. Evoked Potential Monitoring in the Operating Room New York: Raven Press 2002 : 158-161
69 Japaridze G, Kvernadze D, Geladze T, Kevanishvili Z. Effects of carbamazepine on auditory brainstem response, middle-latency response, and slow cortical potential in epileptic patients. Epilepsia . 1993; 34 1105-1109
70 Green J B, Walcoff M R, Lucke J F. Phenytoin prolongs far-field somatosensory and auditory evoked potential interpeak laterencies. Neurology . 1982; 32 85-88
71 Verotti A, Trotta D, Cutarella R. et al . Effects of antiepileptic drugs on evoked potentials in epileptic children. Pediatr Neurol . 2000; 23 397-402
72 Picton T W, Hillyard S A, Drausz H I, Galambos R. Human auditory evoked potentials. I. Evaluation of components. Electroencephalogr Clin Neurophysiol . 174; 36 179-190
73 Deiber M P, Ibanez V, Fischer C. et al . Sequential mapping favours the hypothesis of distinct generators for Na and Pa middle latency auditory evoked potentials. Electroencephalogr Clin Neurophysiol . 1988; 71 187-197
74 Kaga K, Hink R F, Shinoda Y, Suzuki J. Evidence for a primary cortical origin of a middle latency auditory evoked potential in cats. Electroencephalogr Clin Neurophysiol . 1980; 50 254-266
75 Buchwald J S, Rubinstein E H, Schwafel J, Strandburg R J. Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist. Electroencephalogr Clin Neurophysiol . 1991; 80 303-309
76 Boutros N N, Reid M C, Petrakis I. et al . Similarities in the disturbances in cortical information processing in alcoholism and aging: a pilot evoked potential study. Int Psychogeriatr . 2000; 12 513-525
77 Kochs E, Stockmanns G, Thornton C, Nahm W, Kalkman C J. Wavelet analysis of middle latency auditory evoked responses: calculation of an index for detection of awareness during propofol administration. Anesthesiology . 2001; 95 1141-1150
78 Hotz M A, Ritz R, Linder L. et al . Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects. Br J Clin Pharmacol . 2000; 49 72-79
79 Schwender D, Klasing S, Madler C, Poppel E, Peter K. Mid-latency auditory evoked potentials during ketamine anaethesia in humans. Br J Anaesth . 1993; 71 629-632
80 Aoyagi M, Kiren T, Furuse H. et al . Effects of aging on amplitude modulation following response. Acta Otolaryngol Suppl . 1994; 522 15-22
81 Lins O G, Picton T W, Boucher B L. et al . Frequency-specific audiometry using steady-state responses. Ear Hear . 1996; 17 81-96
82 Galambos R, Makeig S, Talmachoff P J. A 40-Hz auditory potential recorded from the human scalp. Proc Natl Acad Sci U S A . 1981; 78 2643-2647
83 Stapells D R, Linden D, Suffield J B. et al . Human auditory steady state potentials. Ear Hear . 1984; 5 105-113
84 Rickards F W, Tan L E, Cohen L T. et al . Auditory steady-state evoked potential in newborns. Br J Audiol . 1994; 28 327-37
85 Rance G, Richards F W, Cohen L T. et al . The automated prediction of hearing thresholds in sleeping subjects using auditory steady-state evoked potentials. Ear Hear . 1995; 16 499-507
86 Lins O G, Pictorn T W. Auditory steady-state response to multiple simultaneous stimuli. Electroencephalogr Clin Neurophysiol . 1995; 96 420-432
87 Goto T, Nakata Y, Saito H. et al . The midlatency auditory evoked potentials predict responsiveness to verbal commands in patients emerging from anesthesia with xenon, isoflurane, and sevoflurane but not with nitrous oxide. Anesthesiology . 2001; 94 782-789
88 Ahveninen J, Tiitinen H, Hirvonen J. et al . Scopolamine augments transient auditory 40-hz magnetic response in humans. Neurosci Lett . 1999; 277 115-118
89 Jaaskelainen I P, Hirovene J, Saher M. et al . Dose-dependent suppression by ethanol of transient auditory 40-Hz response. Psychopharmacology (Berl) . 2000; 148 132-135
90 Jaaskelainen I P, Hirvonen J, Saher M. et al . Benzodiazepine temazepam suppresses the auditory 40-Hz response amplitude in humans. Neurosci Lett . 1999; 268 105-107
91 Plourde G, Villemure C, Fiest P. et al . Effect of isoflurane on the auditory steady-state response and on consciousness in human volunteers. Anesthesiology . 1998; 89 844-851
92 Winkler I, Tervaniemi M, Naatanen R. Two separate codes for missing-fundamental pitch in the human auditory cortex. J Acoust Soc Am . 1997; 102 1072-1082
93 Lang A H, Eerola O, Korpilahti P. et al . Practical issues in the clinical application of mismatch negativity. Ear Hear . 1995; 16 117-129
94 Pekkonen E, Rinne T, Naatanen R. Variability and replicability of the mismatch negativity. Electroencephalogr Clin Neurophysiol . 1995; 96 546-554
95 Umbricht D, Koller R, Vollenweider F X, Schmid L. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry . 2002; 51 400-406
96 Hirvonen J, Jaaskelainen I P, Naatanen R. et al . Adenosine A1/A2a receptors mediate suppression of mismatch negativity by ethanol in humans. Neurosci Lett . 2000; 278 57-60
97 Schwender D, Rimkus T, Haessler R. et al . Effects of increasing doses of alfentanil, fentanyl and morphine on mid-latency auditory evoked potentials. Br J Anaesth . 1993; 71 622-628
98 Picton T W, Hillyard S A. Human auditory evoked potentials. II. Effects of attention. Electroencephalogr Clin Neurophysiol . 1974; 36 191-199
99 Harkrider A W, Champlin C A. Acute effect of nicotine on non-smokers: III. LLRs and EEGs. Hear Res . 2001; 160 99-110
100 Harkrider A W, Champlin C A, McFadden D. Acute effect of nicotine on non-smokers: I. OAEs and ABRs. Hear Res . 2001; 160 89-98
101 Colebatch J G. Vestibular evoked potentials. Curr Opin Neurol . 2001; 14 21-26
102 Matsuzaki M, Murofushi T. Click evoked potentials on the neck of the guinea pig. Hear Res . 2002; 165 152-155